By staff writers

April 11, 2019 -- Colon capsule developer Check-Cap has commenced a U.S. pilot study of its C-Scan system for colorectal cancer screening.

The company said that the first patients in the study have ingested the C-Scan capsule at the New York University School of Medicine. The single-arm pilot study -- which will enroll up to 45 subjects considered to be of average risk for polyps and colon cancer -- will evaluate the safety, usability, and subject compliance of the C-Scan system, according to Check-Cap.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking